Promoting Personalised Medicine By Bringing Functional Proteomics To Pathology
QF-Pro®, a transformative platform that unveils post-translational modifications and protein-protein interactions in pathology samples
FASTBASE´s companion diagnostics platform, QF-Pro®, quantifies protein-protein interactions and protein post-translational modifications in single cell and fixed tissue samples. By design the platform has built in specificity and preserves the morphological integrity and cellular heterogeneity of the tissue. It can be exploited for pharmacodynamics, precision diagnostics and prognostics designed to impact clinical practice.
Powerful Biomarkers for better Treatment Stratification
Protein complexes and protein post translational modifications (PTM) characterise functional states of proteins pertinent to disease. In the microenvironment of a tissue, assessments of these attributes provide markers of disease that are more relevant than simple expression levels of proteins. The QF-Pro® platform can deliver on this information, providing a better route to treatment decisions in cancer, inflammation and immune disorders.
When joining us, you have a unique opportunity to be the one. You are becoming part of the team that’s shaping the next innovation platform for diagnostics, right here and now. You will join a strong, values-driven organization focused on our people and in advancing cutting-edge science.